首页|热毒宁注射液联合氨溴特罗口服溶液和阿奇霉素注射液治疗支原体肺炎患儿的效果

热毒宁注射液联合氨溴特罗口服溶液和阿奇霉素注射液治疗支原体肺炎患儿的效果

扫码查看
目的:观察热毒宁注射液联合氨溴特罗口服溶液和阿奇霉素注射液治疗支原体肺炎患儿的效果.方法:选取 2022 年 5 月至 2023 年 3 月该院收治的 100 例支原体肺炎患儿进行前瞻性研究,按照随机数字表法分为观察组与对照组各 50 例.对照组采用阿奇霉素注射液联合氨溴特罗口服溶液治疗,观察组在对照组基础上加用热毒宁注射液治疗,比较两组治疗总有效率、临床症状缓解时间、血清炎性因子[白细胞介素(IL)-6、肿瘤坏死因子(TNF)-α、γ干扰素(IFN-γ)]水平和不良反应发生率.结果:观察组治疗总有效率为98.00%,明显高于对照组的 82.00%,差异有统计学意义(P<0.05);观察组发热、咳嗽、咳痰、肺部啰音、呼吸困难等临床症状缓解时间均短于对照组,差异有统计学意义(P<0.05);治疗后,两组血清IL-6、TNF-α、IFN-γ水平低于治疗前,且观察组低于对照组,差异均有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:热毒宁注射液联合氨溴特罗口服溶液和阿奇霉素注射液治疗支原体肺炎患儿可提高治疗总有效率,缩短临床症状缓解时间,降低炎性因子水平,效果优于氨溴特罗口服溶液联合阿奇霉素注射液治疗.
Effects of Reduning injection combined withAmbroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution and Azithromycin injection in treatment of children with mycoplasma pneumonia
Objective:To observe effects of Reduning injection combined with Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution and Azithromycin injection in treatment of children with mycoplasma pneumonia.Methods:A prospective study was conducted on 100 children with mycoplasma pneumonia admitted to this hospital from May 2022 to March 2023.According to the random number table method,they were divided into observation group and control group,50 cases in each group.The control group was treated with Azithromycin injection combined with Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution,while the observation group was treated with Reduning injection on the basis of those of the control group.The total effective rate,the remission time of clinical symptoms,the levels of serum inflammatory factors[interleukin(IL)-6,tumor necrosis factor(TNF)-α,interferon-γ(IFN-γ)],and the incidence of adverse reactions were compared between the two groups.Results:The total effective rate of the observation group was 98.00%,which was significantly higher than 82.00%of the control group,and the difference was statistically significant(P<0.05).The remission time of clinical symptoms such as fever,cough,expectoration,lung rales and dyspnea in the observation group were shorter than those in the control group,and the differences were statistically significant(P<0.05).After the treatment,the levels of serum IL-6,TNF-α and IFN-γ in the two groups were lower than those before the treatment,and those in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).However,there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions:Reduning injection combined with Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution and Azithromycin injection in the treatment of the children with mycoplasma pneumonia can improve the total effective rate,shorten the remission time of clinical symptoms,and improve the levels of inflammatory factors.Moreover,it is superior to Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution combined with Azithromycin injection treatment.

Mycoplasma pneumoniaChildrenReduning injectionAmbroxol hydrochloride and Clenbuterol hydrochlorideAzithromycinInflammatory factorAdverse reaction

李金霞、刘慧慧

展开 >

杞县人民医院儿科,河南 开封 475200

支原体肺炎 儿童 热毒宁注射液 氨溴特罗 阿奇霉素 炎性因子 不良反应

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(3)
  • 13